Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.174.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -26.89% | -9.11% | 34.12% | 455.81% | 162.39% |
| Total Receivables | -62.50% | -95.56% | -30.07% | 23.44% | 502.35% |
| Inventory | -70.13% | -16.78% | 8.78% | 103.02% | -- |
| Prepaid Expenses | 22.89% | -15.14% | 72.96% | 97.61% | 126.89% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 161.29% | 101.38% | -- |
| Total Current Assets | -23.47% | -15.85% | 30.16% | 346.25% | 169.28% |
|
|
|||||
| Total Current Assets | -23.47% | -15.85% | 30.16% | 346.25% | 169.28% |
| Net Property, Plant & Equipment | 21.40% | 24.54% | 46.27% | -0.12% | 12.38% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -100.00% | -74.17% | -74.18% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -66.74% | -57.34% | -49.81% | -39.10% | 6.14% |
| Total Assets | -41.72% | -33.02% | -26.58% | -37.43% | -32.39% |
|
|
|||||
| Total Accounts Payable | 46.52% | -29.14% | 55.03% | 21.10% | 21.50% |
| Total Accrued Expenses | 90.69% | 52.13% | 77.48% | -1.42% | 12.20% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.04% | 25.50% | 39.54% | 24.55% | 49.66% |
| Total Finance Division Other Current Liabilities | 2.47% | -63.28% | 87.72% | -63.93% | -70.22% |
| Total Other Current Liabilities | 2.47% | -63.28% | 87.72% | -63.93% | -70.22% |
| Total Current Liabilities | 54.63% | 23.98% | 65.98% | -15.73% | -7.59% |
|
|
|||||
| Total Current Liabilities | 54.63% | 23.98% | 65.98% | -15.73% | -7.59% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -50.11% | -36.98% | -28.66% | -43.54% | -30.48% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -3.40% | -1.51% | 15.23% | -9.78% | -2.96% |
| Total Liabilities | 2.68% | 1.95% | 20.83% | -12.18% | -4.99% |
|
|
|||||
| Common Stock & APIC | 7.33% | 7.32% | 9.16% | 12.81% | 12.80% |
| Retained Earnings | -13.45% | -13.39% | -14.33% | -19.17% | -20.89% |
| Treasury Stock & Other | -21.18% | 73.17% | 309.52% | 50.88% | 129.73% |
| Total Common Equity | -2,039.80% | -204.63% | -156.35% | -194.70% | -95.16% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2,039.80% | -204.63% | -156.35% | -194.70% | -95.16% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2,039.80% | -204.63% | -156.35% | -194.70% | -95.16% |
|
|
|||||